VL285 is primarily utilized in research settings as a selective inhibitor targeting specific enzymes or proteins involved in cellular signaling pathways. Its application is significant in studying the mechanisms of diseases where these pathways are dysregulated, such as cancer or neurodegenerative disorders. Researchers employ VL285 to understand the role of these targets in disease progression and to evaluate potential therapeutic strategies. Additionally, it serves as a valuable tool in drug discovery, helping to identify and validate new targets for pharmacological intervention. Its selectivity and potency make it a critical compound in preclinical studies aimed at developing novel treatments.